ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,799Medicare Part D Prescriptions Filled, Including Refills

Rank: 75 out of 917

$517K Total Retail Price of All Prescriptions

Rank: 108 out of 917

553 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 553 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

11% of this provider’s 553 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 9,454 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LEVOTHYROXINE SODIUM 684 591 1 3
ATENOLOL 468 455 2 12
LISINOPRIL 438 414 3 1
HYDROCODONE-ACETAMINOPHEN 372 302 S3 4 6
OMEPRAZOLE 335 302 5 4
POTASSIUM CHLORIDE 317 293 6 16
HYDROCHLOROTHIAZIDE 295 283 7 9
WARFARIN SODIUM 273 262 8 10
ATORVASTATIN CALCIUM 266 258 9 14
SIMVASTATIN 258 234 10 2
AMLODIPINE BESYLATE 248 228 11 5
LOSARTAN POTASSIUM 232 221 12 13
FUROSEMIDE 221 207 13 7
METFORMIN HCL 204 194 14 8
PRAVASTATIN SODIUM 193 168 15 20
ALLOPURINOL 170 169 16 31
METOPROLOL TARTRATE 163 158 17 11
SERTRALINE HCL 151 129 18 24
CITALOPRAM HBR 147 117 19 15
ZOLPIDEM TARTRATE 137 121 20 21
GABAPENTIN 130 92 21 17
FLUTICASONE PROPIONATE 124 101 22 26
LOVASTATIN 122 112 23 19
TRIAMTERENE-HCTZ 118 102 24 36
METOPROLOL SUCCINATE 114 110 25 18
ALENDRONATE SODIUM 106 86 26 23
TRAMADOL HCL 105 103 27 28
PANTOPRAZOLE SODIUM 88 70 28 44
OXYCODONE-ACETAMINOPHEN 84 32 S2 29 46
TRAZODONE HCL 81 55 30 22
DIGOXIN 77 74 31 41
PREDNISONE 76 73 32 34
ADVAIR DISKUS 71 71 33 47
RANITIDINE HCL 67 52 34 29
LANTUS SOLOSTAR 66 59 35 63
LIPITOR 65 65 36 89
TAMSULOSIN HCL 62 62 37 25
OXYCODONE HCL 58 34 S2 38 27
NIFEDIPINE ER 56 56 39 139
ENDOCET 55 0 S2 40 210
MORPHINE SULFATE ER 55 0 S2 40 48
LANTUS 54 52 42 37
BENAZEPRIL HCL 54 54 42 80
DIOVAN 53 52 44 49
CARBIDOPA-LEVODOPA 53 53 44 86
SPIRIVA 52 43 46 45
COMBIVENT 50 50 47 148
ROPINIROLE HCL 50 44 47 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.